News
The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, highlighting notable ocular toxicities and missed opportunities for dosing ...
Corona Remedies acquires cardiology and women's healthcare brands from Bayer, entering new segments ahead of IPO.
This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...
The U.S. Food and Drug Administration's panel of independent advisers voted on Thursday against approval of GSK's blood ...
Jeremy Siegel, professor emeritus of finance at the University of Pennsylvania’s Wharton School of Business and Wisdom Tree chief economist, appeared on CNBC’s ‘Squawk Box’ to ...
GSK (GSK) stock in focus as the U.S. FDA approves a new prefilled syringe presentation of its shingles vaccine, Shingrix.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.
4h
Zacks Investment Research on MSNHow to Boost Your Portfolio with Top Medical Stocks Set to Beat EarningsWall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...
Slack launches comprehensive AI features including enterprise search and writing assistance as Salesforce challenges Microsoft's workplace AI dominance while blocking rival access to platform data.
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe ...
The syringe removes the need to reconstitute separate vials prior to administration, which simplifies the vaccine administration process for healthcare professionals, GSK said Thursday. The existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results